Skip to main content
. 2020 Oct 7;37(20):2198–2210. doi: 10.1089/neu.2019.6577

Table 6B.

Mediation Model of the Relationship between T1 and T2 Tumor Necrosos Factor Alpha and Six-Month Mortality

Mediators (analyzed separately) Association between T1 TNFα and mediator T1 TNFα
Association between T2 TNFα and mediator T2 TNFα
 
 
Total effect Direct effect Mediation % Total effect Direct effect Mediation %
  OR (95% CI) OR (95% CI) OR (95% CI)   OR (95% CI) OR (95% CI) OR (95% CI)  
1. Cardiovascular dysfunction 1.29 (0.80, 2.07) 2.19 (1.19, 4.03)* 2.22 (1.17, 4.24)* †† 2.36 (1.33, 4.19)* 2.89 (1.47, 5.67)* 2.47 (1.24, 4.92)* 20.01¥
2. Hematology dysfunction 1.49 (0.86, 2.58) 2.64 (1.28, 5.46)* 2.56 (1.26, 5.34)* 3.81¥ 1.94 (1.07, 3.53)* 3.77 (1.67, 8.50)* 3.63 (1.58, 8.32)* 3.41¥
3. Renal dysfunction 4.78 (2.00, 11.44)* 3.20 (1.46, 6.98)* 2.37 (1.00, 5.59)* 30.13¥ 4.28 (1.81, 10.14)* 3.76 (1.64, 8.59)* 2.68 (1.08, 6.64)* 29.70¥
4. Hepatic dysfunction 1.11 (0.47, 2.60) 2.11 (1.06, 4.19)* 2.13 (1.04, 4.35) †† 3.08 (1.30, 7.30)* 3.82 (1.69, 8.65)* 3.44 (1.47, 8.06)* 10.34¥
5. Respiratory dysfunction 1.02 (0.53, 1.98) 2.36 (1.24, 4.50)* 2.36 (1.24, 4.50)* †† 1.23 (0.54, 2.80) 3.81 (1.77, 8.22)* 3.82 (1.77, 8.26)* ††
  IRR (95% CI) OR (95% CI) OR (95% CI) Mediation % IRR (95% CI) OR (95% CI) OR (95% CI) Mediation %
6. Total count of system dysfunction 1.21 (0.97, 1.49) 3.34 (1.41, 7.90)* 3.10 (1.23, 7.78)* 13.02¥ 1.32 (1.07, 1.63)* 6.34 (2.13, 18.89)* 5.31 (1.63, 17.30)* 15.14¥

TNFα, tumor necrosis factor alpha; OR, odds ratio; CI, confidence interval; IRR, incidence rate ratio.

*

Indicates p < 0.05; All paths adjusted for age and sex.

††

: Total effect not significant and/or total effect ≤ direct effect, mediation % not calculated.

¥: Indicates a partial mediator.

€: Indicates a full mediator.